by admin | May 15, 2023 | News & Opinions
By Michael Irving – News Atlas Scientists in Canada have developed a new technique that may one day help restore some sight to patients with inherited vision impairment. The regenerative therapy works by expressing genes that convert dormant cells into new...
by admin | May 14, 2023 | News & Opinions
Intrathecal mesenchymal stem cell-neural progenitor therapy failed to significantly improve the EDSS or the EDSS Plus versus placebo in progressive MS. by Physician’s Weekly Mesenchymal stem cell-neural progenitor therapy (MSC-NPs) are bone marrow-derived cells...
by admin | May 13, 2023 | News & Opinions
STING-seq provides roadmap to identify variants and genes, enabling deeper understanding of the noncoding genome and targets for therapies By NYU News A major challenge in human genetics is understanding which parts of the genome drive specific traits or contribute to...
by admin | May 12, 2023 | News & Opinions
by Justin Jackson – Phys.org Researchers at Sana Biotechnology, Inc., in California, have made a significant breakthrough in realizing the promise of stem cell therapy: stem cells that do not trigger an immune response from an immunologically incompatible donor....
by admin | May 10, 2023 | News & Opinions
By Longeveron MIAMI, May 09, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced new...
by admin | May 9, 2023 | News & Opinions
by Innovation Quarter Some things are worth traveling for. We drive the extra hour to one-of-a-kind restaurants, we cross state lines for best-in-class specialists and we travel days to experience unrivaled natural wonders. One day, there will be products that we have...